Bliss GVS Pharma Limited — Others, 30-06-2025: Copy of Newspaper Publication

Bliss GVS Pharma has announced a notice to shareholders regarding the transfer of unclaimed final dividend for 2017-18 and the corresponding equity shares to the Investor Education and Protection Fund (IEPF) Authority. This move affects shareholders who have not claimed their dividend or shares for this period. Shareholders are advised to take note as unclaimed amounts and shares will be transferred, impacting their entitlement unless acted upon. This update underscores the company’s compliance with statutory requirements and ensures better clarity on pending dividend distributions.